421 related articles for article (PubMed ID: 6342687)
21. Enhanced thrombolysis in plasma and in vivo by single-chain urokinase-type plasminogen activator (scuPA) conjugated to an antifibrin antibody.
Bode C; Runge M; Eberle T; Freitag M; Kübler W; Haber E
Trans Assoc Am Physicians; 1989; 102():7-12. PubMed ID: 2517856
[No Abstract] [Full Text] [Related]
22. [Development of research into the physiology and pathophysiology of the fibrinolysis system].
Andreenko GV
Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (10):5-19. PubMed ID: 2933082
[TBL] [Abstract][Full Text] [Related]
23. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosis.
Collen D; Stassen JM; Blaber M; Winkler M; Verstraete M
Thromb Haemost; 1984 Aug; 52(1):27-30. PubMed ID: 6541817
[TBL] [Abstract][Full Text] [Related]
24. Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).
Lipinski B; Gurewich V; Hyde E
Thromb Diath Haemorrh; 1975 Sep; 34(1):351. PubMed ID: 1188799
[No Abstract] [Full Text] [Related]
25. [Effect of a single administration of plasminogen tissue activator on the state of the fibrinolytic system of rat blood].
Andreenko GV; Shimonaeva EE; Liutova LV; Serebriakova TN
Vopr Med Khim; 1981; 27(1):77-80. PubMed ID: 7193381
[TBL] [Abstract][Full Text] [Related]
26. Vasodilation, fibrinolysis, and thrombolysis with intraarterial infusion of urokinase in the canine superior mesenteric artery.
Gurll N; Zinner MJ; Turtinen L; Reynolds DG
Gastroenterology; 1978 Sep; 75(3):425-31. PubMed ID: 98390
[TBL] [Abstract][Full Text] [Related]
27. Activation of the fibrinolytic system.
Robison AK; Collen D
Cardiol Clin; 1987 Feb; 5(1):13-9. PubMed ID: 3103919
[TBL] [Abstract][Full Text] [Related]
28. Fibrinolytic agents: mechanisms of activity and pharmacology.
Lijnen HR; Collen D
Thromb Haemost; 1995 Jul; 74(1):387-90. PubMed ID: 8578491
[TBL] [Abstract][Full Text] [Related]
29. [Thrombolytics and their use].
Alessi MC; Juhan-Vague I
Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
[TBL] [Abstract][Full Text] [Related]
30. [The vasomotor effects of the enzymes of the fibrinolytic system in rats].
Sergeev IIu; Bashkov GV
Fiziol Zh Im I M Sechenova; 1996; 82(10-11):52-7. PubMed ID: 9162395
[TBL] [Abstract][Full Text] [Related]
31. [Molecular interactions during fibrinolysis. Search for new plasminogen activators].
Maksimenko AV
Mol Biol (Mosk); 1995; 29(1):38-60. PubMed ID: 7723763
[TBL] [Abstract][Full Text] [Related]
32. [The fibrinolytic system and its activators].
Seifried E
Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
[TBL] [Abstract][Full Text] [Related]
33. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
Collen D; Lijnen HR
Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
[TBL] [Abstract][Full Text] [Related]
34. Immobilization of plasminogen activator, urokinase, on nylon.
Sugitachi A; Takagi K; Imaoka S; Kosaki G
Thromb Haemost; 1978 Apr; 39(2):426-36. PubMed ID: 580991
[TBL] [Abstract][Full Text] [Related]
35. Effects of pro-urokinase and urokinase on the fibrinolytic system in man.
Trübestein G; Popov S; Wolf H; Welzel D
Haemostasis; 1987; 17(4):238-44. PubMed ID: 2442078
[TBL] [Abstract][Full Text] [Related]
36. [Pharmacological potentials for activating the fibrinolytic system].
Markwardt F
Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
[TBL] [Abstract][Full Text] [Related]
37. [Heparin and urokinase interactions in the fibrinolytic system].
Villaverde CA; Badimón L; Badimón JJ; Valdecasas FG
Arch Farmacol Toxicol; 1979 Dec; 5(3):268-9. PubMed ID: 397804
[No Abstract] [Full Text] [Related]
38. [Effect of tricholysine on plasma fibrinolytic activity].
Serebriakova TN; Andreenko GV; Maksimova RA
Nauchnye Doki Vyss Shkoly Biol Nauki; 1981; (8):46-51. PubMed ID: 7196773
[No Abstract] [Full Text] [Related]
39. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
[TBL] [Abstract][Full Text] [Related]
40. [Anticoagulating properties of fungal proteases tricholysine (triase) and longolytin].
Serebriakova TN; Andreenko GV; Maksimova RA; Tsymanovich ST; Murashova NL
Vopr Med Khim; 1984; 30(5):37-40. PubMed ID: 6396943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
